Chemistry of Life Processes Institute’s groundbreaking technologies for the analysis of human proteins distinguishes Northwestern as a world leader in the fast-growing field of proteomics and protein sequencing, the next great wave in discovery science. Institute faculty and clinicians in Feinberg School of Medicine work together to apply this new knowledge of protein structure and function to create more sensitive diagnostics and identify new targets for drug development and delivery.

With a bold focus on cancer and diseases of the brain, the Institute has made several important breakthroughs for people living with ALS and Alzheimer’s disease, prostate cancer, and more through our unmatched expertise in identifying and measuring all the various forms of human proteins in our cells (proteoforms).

Our goal over the next five years is to extend these transformative capabilities to new treatments and diagnostics for not only cancer and neurodegenerative diseases, but also heart, kidney and liver disease and transplant rejection. In doing so, CLP will help launch a new era of precision medicine driven by precision proteomics.

Simultaneously, CLP provides foundational research experiences and hands-on training for the next generation of scientific leaders instilling cross-disciplinary skills and methods that prepare them for successful careers in academia, medicine, industry, and other areas.